Cargando…

Late-onset hypogonadism

In Poland, the number of men over the age of 50 years exceeds 6 million. It is estimated that about 2-6% of this population develops symptoms of late-onset hypogonadism (LOH). In men, testosterone deficiency increases slightly with age. LOH is a clinically and biochemically defined disease of older...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudek, Piotr, Kozakowski, Jarosław, Zgliczyński, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509975/
https://www.ncbi.nlm.nih.gov/pubmed/28721133
http://dx.doi.org/10.5114/pm.2017.68595
_version_ 1783250105094111232
author Dudek, Piotr
Kozakowski, Jarosław
Zgliczyński, Wojciech
author_facet Dudek, Piotr
Kozakowski, Jarosław
Zgliczyński, Wojciech
author_sort Dudek, Piotr
collection PubMed
description In Poland, the number of men over the age of 50 years exceeds 6 million. It is estimated that about 2-6% of this population develops symptoms of late-onset hypogonadism (LOH). In men, testosterone deficiency increases slightly with age. LOH is a clinically and biochemically defined disease of older men with serum testosterone level below the reference parameters of younger healthy men and with symptoms of testosterone deficiency, manifested by pronounced disturbances of quality of life and harmful effects on multiple organ systems. Testosterone replacement therapy may give several benefits regarding body composition, metabolic control, and psychological and sexual parameters.
format Online
Article
Text
id pubmed-5509975
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-55099752017-07-18 Late-onset hypogonadism Dudek, Piotr Kozakowski, Jarosław Zgliczyński, Wojciech Prz Menopauzalny Review Paper In Poland, the number of men over the age of 50 years exceeds 6 million. It is estimated that about 2-6% of this population develops symptoms of late-onset hypogonadism (LOH). In men, testosterone deficiency increases slightly with age. LOH is a clinically and biochemically defined disease of older men with serum testosterone level below the reference parameters of younger healthy men and with symptoms of testosterone deficiency, manifested by pronounced disturbances of quality of life and harmful effects on multiple organ systems. Testosterone replacement therapy may give several benefits regarding body composition, metabolic control, and psychological and sexual parameters. Termedia Publishing House 2017-06-30 2017-06 /pmc/articles/PMC5509975/ /pubmed/28721133 http://dx.doi.org/10.5114/pm.2017.68595 Text en Copyright: © 2017 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Review Paper
Dudek, Piotr
Kozakowski, Jarosław
Zgliczyński, Wojciech
Late-onset hypogonadism
title Late-onset hypogonadism
title_full Late-onset hypogonadism
title_fullStr Late-onset hypogonadism
title_full_unstemmed Late-onset hypogonadism
title_short Late-onset hypogonadism
title_sort late-onset hypogonadism
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509975/
https://www.ncbi.nlm.nih.gov/pubmed/28721133
http://dx.doi.org/10.5114/pm.2017.68595
work_keys_str_mv AT dudekpiotr lateonsethypogonadism
AT kozakowskijarosław lateonsethypogonadism
AT zgliczynskiwojciech lateonsethypogonadism